The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACCURAY INC | COM | 004397105 | 14,094 | 1,515,475 | SH | SOLE | 1,515,475 | 0 | 0 | 0 | |
ACHAOGEN INC | COM | 004449104 | 3,888 | 398,340 | SH | SOLE | 398,340 | 0 | 0 | 0 | |
AETNA INC NEW | COM | 00817Y108 | 22,582 | 211,974 | SH | SOLE | 211,974 | 0 | 0 | 0 | |
ALERE INC | COM | 01449J105 | 32,476 | 664,138 | SH | SOLE | 664,138 | 0 | 0 | 0 | |
ALEXION PHARMACEUTICALS INC | COM | 015351109 | 241 | 1,390 | SH | SOLE | 1,390 | 0 | 0 | 0 | |
AMICUS THERAPEUTICS INC | COM | 03152W109 | 63,455 | 5,832,228 | SH | SOLE | 5,832,228 | 0 | 0 | 0 | |
ARRAY BIOPHARMA INC | COM | 04269X105 | 96,736 | 13,125,594 | SH | SOLE | 13,125,594 | 0 | 0 | 0 | |
ARRAY BIOPHARMA INC | NOTE 3.000% 6/0 | 04269XAA3 | 5,022 | 4,000,000 | PRN | SOLE | 4,000,000 | 0 | 0 | 0 | |
ATARA BIOTHERAPEUTICS INC | COM | 046513107 | 11,025 | 265,205 | SH | SOLE | 265,205 | 0 | 0 | 0 | |
AUSPEX PHARMACEUTICALS INC | COM | 05211J102 | 41,866 | 417,533 | SH | SOLE | 417,533 | 0 | 0 | 0 | |
AVALANCHE BIOTECHNOLOGIES IN | COM | 05337G107 | 17,064 | 421,133 | SH | SOLE | 421,133 | 0 | 0 | 0 | |
BELLICUM PHARMACEUTICALS INC | COM | 079481107 | 9,284 | 445,221 | SH | SOLE | 445,221 | 0 | 0 | 0 | |
BIOGEN INC | COM | 09062X103 | 41,258 | 97,713 | SH | SOLE | 97,713 | 0 | 0 | 0 | |
BIOSCRIP INC | COM | 09069N108 | 6,105 | 1,378,200 | SH | SOLE | 1,378,200 | 0 | 0 | 0 | |
CASTLIGHT HEALTH INC | CL B | 14862Q100 | 18,131 | 2,336,498 | SH | SOLE | 2,336,498 | 0 | 0 | 0 | |
CELLDEX THERAPEUTICS INC NEW | COM | 15117B103 | 15,245 | 547,000 | SH | SOLE | 547,000 | 0 | 0 | 0 | |
CERUS CORP | COM | 157085101 | 6,871 | 1,647,727 | SH | SOLE | 1,647,727 | 0 | 0 | 0 | |
CHEMOCENTRYX INC | COM | 16383L106 | 132 | 17,500 | SH | SOLE | 17,500 | 0 | 0 | 0 | |
CHIMERIX INC | COM | 16934W106 | 31,828 | 844,456 | SH | SOLE | 844,456 | 0 | 0 | 0 | |
CIVITAS SOLUTIONS INC | COM | 17887R102 | 18,416 | 879,485 | SH | SOLE | 879,485 | 0 | 0 | 0 | |
CLOVIS ONCOLOGY INC | COM | 189464100 | 66,872 | 900,879 | SH | SOLE | 900,879 | 0 | 0 | 0 | |
DAVITA HEALTHCARE PARTNERS I | COM | 23918K108 | 21,609 | 265,858 | SH | SOLE | 265,858 | 0 | 0 | 0 | |
ELEVEN BIOTHERAPEUTICS INC | COM | 286221106 | 2,141 | 240,000 | SH | SOLE | 240,000 | 0 | 0 | 0 | |
ENDO INTL PLC | SHS | G30401106 | 50,272 | 560,443 | SH | SOLE | 560,443 | 0 | 0 | 0 | |
FLEXION THERAPEUTICS INC | COM | 33938J106 | 4,270 | 189,624 | SH | SOLE | 189,624 | 0 | 0 | 0 | |
FLUIDIGM CORP DEL | COM | 34385P108 | 23,679 | 562,437 | SH | SOLE | 562,437 | 0 | 0 | 0 | |
GENOCEA BIOSCIENCES INC | COM | 372427104 | 9,451 | 796,900 | SH | SOLE | 796,900 | 0 | 0 | 0 | |
GLOBUS MED INC | CL A | 379577208 | 15,440 | 611,731 | SH | SOLE | 611,731 | 0 | 0 | 0 | |
GW PHARMACEUTICALS PLC | ADS | 36197T103 | 10,855 | 119,114 | SH | SOLE | 119,114 | 0 | 0 | 0 | |
HEALTH NET INC | COM | 42222G108 | 16,354 | 270,358 | SH | SOLE | 270,358 | 0 | 0 | 0 | |
HEALTHWAYS INC | COM | 422245100 | 21,158 | 1,074,033 | SH | SOLE | 1,074,033 | 0 | 0 | 0 | |
INSMED INC | COM PAR $.01 | 457669307 | 28,742 | 1,381,828 | SH | SOLE | 1,381,828 | 0 | 0 | 0 | |
INTRA CELLULAR THERAPIES INC | COM | 46116X101 | 15,968 | 668,671 | SH | SOLE | 668,671 | 0 | 0 | 0 | |
INVITAE CORP | COM | 46185L103 | 10,946 | 785,131 | SH | SOLE | 125,000 | 0 | 0 | 0 | |
ISHARES | US HLTHCR PR ETF | 464288828 | 1,144 | 8,599 | SH | SOLE | 8,599 | 0 | 0 | 0 | |
JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | 17,279 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | 0 | |
KYTHERA BIOPHARMACEUTICALS I | COM | 501570105 | 11,287 | 225,062 | SH | SOLE | 225,062 | 0 | 0 | 0 | |
MARKET VECTORS ETF TR | PHARMACEUTICAL | 57060U217 | 457 | 6,500 | SH | SOLE | 6,500 | 0 | 0 | 0 | |
MODEL N INC | COM | 607525102 | 17,482 | 1,461,678 | SH | SOLE | 1,461,678 | 0 | 0 | 0 | |
NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | 10,981 | 1,077,642 | SH | SOLE | 1,077,642 | 0 | 0 | 0 | |
NUVASIVE INC | COM | 670704105 | 8,514 | 185,137 | SH | SOLE | 185,137 | 0 | 0 | 0 | |
OTONOMY INC | COM | 68906L105 | 2,792 | 78,972 | SH | SOLE | 78,972 | 0 | 0 | 0 | |
OXFORD IMMUNOTEC GLOBAL PLC | ORD SHS | G6855A103 | 19,930 | 1,415,482 | SH | SOLE | 1,415,482 | 0 | 0 | 0 | |
POWERSHARES QQQ TRUST | UNIT SER 1 | 73935A104 | 454 | 4,300 | SH | SOLE | 4,300 | 0 | 0 | 0 | |
PROQR THRAPEUTICS N V | SHS EURO | N71542109 | 16,436 | 751,171 | SH | SOLE | 498,085 | 0 | 0 | 0 | |
RECEPTOS INC | COM | 756207106 | 26,286 | 159,413 | SH | SOLE | 159,413 | 0 | 0 | 0 | |
SEATTLE GENETICS INC | COM | 812578102 | 37,212 | 1,052,666 | SH | SOLE | 1,052,666 | 0 | 0 | 0 | |
TEKMIRA PHARMACEUTICALS CORP | COM NEW | 87911B209 | 12,222 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | 0 | |
TEVA PHARMACEUTICAL INDS LTD | ADR | 881624209 | 53,203 | 853,973 | SH | SOLE | 853,973 | 0 | 0 | 0 | |
TRIVASCULAR TECHNOLOGIES INC | COM | 89685A102 | 16,665 | 1,588,623 | SH | SOLE | 1,588,623 | 0 | 0 | 0 | |
ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 20,651 | 332,600 | SH | SOLE | 332,600 | 0 | 0 | 0 | |
VALEANT PHARMACEUTICALS INTL | COM | 91911K102 | 53,333 | 268,519 | SH | SOLE | 268,519 | 0 | 0 | 0 | |
VCA INC | COM | 918194101 | 16,874 | 307,804 | SH | SOLE | 307,804 | 0 | 0 | 0 | |
ZS PHARMA INC | COM | 98979G105 | 17,071 | 405,688 | SH | SOLE | 405,688 | 0 | 0 | 0 |